Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103694176A details a high-yield route for nilotinib intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN104059016A offers high-yield route for tofacitinib intermediates. Reduces steps and cost for pharmaceutical manufacturing supply chains.
Novel low-cost process for Rimegepant intermediate using urea. Reduces raw material costs and enhances industrial scalability for pharmaceutical supply chains globally.
Advanced patent CN104016961A enables efficient Rosuvastatin intermediate production. Discover cost-effective, scalable synthesis routes for global supply chains.
Patent CN107501364B reveals improved oxalate salt synthesis for Tulathromycin intermediates offering higher yield and milder conditions for veterinary drug manufacturing supply chains.
Patent CN106800539B reveals a safer route for acotiamide intermediates. Achieve high purity and simplified purification for reliable pharmaceutical supply chains.
Patent CN1322200A details a scalable enantioselective synthesis for non-steroidal antiestrogen intermediates. Discover cost reduction in pharmaceutical manufacturing and supply chain advantages.
Patent CN109232494B reveals a superior (S)-BINAL-H reduction method for bimatoprost intermediates, offering enhanced chiral purity and streamlined manufacturing for global supply chains.
Novel synthesis of Cholic Acid Intermediate A4 via patent CN116023424B. Ensures high purity, avoids animal extraction risks, and offers scalable commercial production for global supply chains.
Patent CN110964703B reveals high-efficiency ketoreductase for duloxetine intermediate. Achieve cost reduction and supply reliability in pharmaceutical manufacturing.
Patent CN107022587A details a novel enzymatic route for Ezetimibe intermediates using tubular reactors. Discover cost reduction in API manufacturing and high-purity supply solutions.
Patent CN106674069A reveals high-purity isomerization method. Enables cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier solutions.
Patent CN103554031B reveals a cost-effective route for Azilsartan intermediates with reduced impurities and scalable hydroxylamine chemistry for reliable supply chains.
Novel patent CN117756611A offers efficient synthesis of dapagliflozin intermediate. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical partners.
Patent CN117105909A reveals a mild one-step synthesis for Lasmiditan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel aminotransferase patent enables high-purity sitagliptin intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Novel aldol cyclization route for eribulin intermediate reduces cost and improves scalability for pharmaceutical supply chains globally ensuring high purity standards.
Advanced synthesis of Epacadostat intermediates via patent CN108101899A. Offers mild conditions, high purity, and scalable pharmaceutical intermediate manufacturing solutions.
Novel 3-step synthesis for carbapenem antibiotics offering high yield and mild conditions for reliable supply chain integration.
Advanced synthesis of bendamustine intermediate via reductive alkylation. Superior purity >99.5% and optimized yield for reliable pharmaceutical supply chains.